Oracea® targets the pathophysiology of rosacea—inflammation

Only Oracea has been shown to isolate anti-inflammatory effects without exerting antimicrobial actions.2

With Oracea, the steady-state of doxycycline remains below the antimicrobial threshold, avoiding the complications associated with antimicrobial activity†3

  • While the exact cause is unknown, chronic inflammation plays a primary role in rosacea4
  • Tetracycline antibiotics exert anti-inflammatory activity, but are associated with dose-related side effects and an increased risk of bacterial resistance5

*Oracea is indicated for the treatment of only inflammatory lesions (papules and pustules) of rosacea in adult patients.

Please see the full prescribing information.

Click here to view references »